BDAZ/fouremm - My understanding is the same as fouremm's. When the spin-off happened there were 75 million shares of Zenith Epigenetics Inc which is now Zenith Capital Corp that currently has 125 mil shs outstanding (132 mil fully diluted) and Zenith Epigenetics Ltd is the operating company with all the IP. If the funds raised are through Zenith Capital Corp then I believe that would represent the third dilutive event to the royalties which as fouremm stated is exactly opposite from what we have been told on a number of occasions.

This is IMO

tada